A Study To Compare The Efficacy And Safety Of Pegvisomant To That Of Sandostatin Lar Depot In Patients With Acromegaly
NCT00068042
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
100
Enrollment
INDUSTRY
Sponsor class
Conditions
Acromegaly
Interventions
DRUG:
Pegvisomant
DRUG:
Sandostatin LAR
Sponsor
Pfizer